Dexcom Inc
NASDAQ:DXCM
Dexcom Inc
Interest Income Expense
Dexcom Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dexcom Inc
NASDAQ:DXCM
|
Interest Income Expense
$116.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Interest Income Expense
-$384m
|
CAGR 3-Years
9%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-16%
|
|
Boston Scientific Corp
NYSE:BSX
|
Interest Income Expense
-$537m
|
CAGR 3-Years
-325%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
-5%
|
|
Stryker Corp
NYSE:SYK
|
Interest Income Expense
-$281m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Abbott Laboratories
NYSE:ABT
|
Interest Income Expense
-$296m
|
CAGR 3-Years
16%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Interest Income Expense
$227m
|
CAGR 3-Years
11%
|
CAGR 5-Years
19%
|
CAGR 10-Years
29%
|
See Also
What is Dexcom Inc's Interest Income Expense?
Interest Income Expense
116.6m
USD
Based on the financial report for Dec 31, 2023, Dexcom Inc's Interest Income Expense amounts to 116.6m USD.
What is Dexcom Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
14%